Home › Degenerasyon ng Macula
Pag-aaral pangklinika para sa Degenerasyon ng Macula na nagre-recruit sa U.S.
55 pag-aaral para sa Degenerasyon ng Macula ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Dallas, TX13 pag-aaral
- Erie, PA10 pag-aaral
- The Woodlands, TX9 pag-aaral
- Hagerstown, MD8 pag-aaral
- Reno, NV8 pag-aaral
- Sacramento, CA8 pag-aaral
- Santa Monica, CA7 pag-aaral
- Houston, TX7 pag-aaral
- Fort Worth, TX7 pag-aaral
- Boston, MA7 pag-aaral
- Salt Lake City, UT7 pag-aaral
- Austin, TX7 pag-aaral
- Carmel, IN7 pag-aaral
- Cleveland, OH7 pag-aaral
- Phoenix, AZ7 pag-aaral
- Mountain View, CA6 pag-aaral
- Raleigh, NC6 pag-aaral
- Naperville, IL6 pag-aaral
- Columbia, SC6 pag-aaral
- Nashville, TN6 pag-aaral
- Cincinnati, OH6 pag-aaral
- Washington, DC6 pag-aaral
- Philadelphia, PA6 pag-aaral
- McAllen, TX6 pag-aaral
- Portland, OR6 pag-aaral
- San Francisco, CA5 pag-aaral
- Eugene, OR5 pag-aaral
- Orlando, FL5 pag-aaral
- San Antonio, TX5 pag-aaral
- Spokane, WA5 pag-aaral
- Fort Lauderdale, FL5 pag-aaral
- Durham, NC5 pag-aaral
- Lynchburg, VA5 pag-aaral
- Syracuse, NY5 pag-aaral
- Pensacola, FL5 pag-aaral
- Tampa, FL5 pag-aaral
- Sarasota, FL4 pag-aaral
- Colorado Springs, CO4 pag-aaral
- Cypress, TX4 pag-aaral
- Cary, NC4 pag-aaral
Ayos sa estado
- Arizona11 pag-aaral
- California20 pag-aaral
- Colorado7 pag-aaral
- Connecticut6 pag-aaral
- Florida14 pag-aaral
- Georgia6 pag-aaral
- Illinois13 pag-aaral
- Indiana7 pag-aaral
- Maryland11 pag-aaral
- Massachusetts14 pag-aaral
- Michigan9 pag-aaral
- Minnesota5 pag-aaral
- Mississippi5 pag-aaral
- Missouri5 pag-aaral
- Nevada8 pag-aaral
- New Jersey7 pag-aaral
- New York10 pag-aaral
- North Carolina11 pag-aaral
- Ohio11 pag-aaral
- Oklahoma3 pag-aaral
- Oregon9 pag-aaral
- Pennsylvania17 pag-aaral
- South Carolina8 pag-aaral
- Tennessee7 pag-aaral
- Texas24 pag-aaral
- Utah9 pag-aaral
- Virginia7 pag-aaral
- Washington8 pag-aaral
- Wisconsin6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Nagre-recruitPhase 2/3
Edad 60 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06635148National Eye Institute Biorepository for Retinal Diseases
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 120 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01496625A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Nagre-recruitPhase 1/2
Edad 55 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07029945Cell Collection to Study Eye Diseases
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Day – 120 Years · Lahat ng kasarian · Na-update Set 22, 2026 · NCT01432847A Study in Adults With Geographic Atrophy
Nagre-recruitPhase 2
Edad 60 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07606365A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Nagre-recruitPhase 2/3
Edad 50 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07440225A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Nagre-recruitPhase 3
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06541704A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
Nagre-recruitPhase 1
Edad 6 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07734064A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
Nagre-recruitPhase 2
Edad 50 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07811726The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06319872Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Nagre-recruitPhase 2
Edad 55 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Nagre-recruitObservasyonal na pag-aaral
Edad 55 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07144137Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
Nagre-recruitObservasyonal na pag-aaral
Edad 50 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07798323A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Nagre-recruitPhase 1
Edad 50 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT03178149A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Nagre-recruitObservasyonal na pag-aaral
Edad 50 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06346600Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06965426Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Nagre-recruit
Edad 60 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06662162SGLT2 Inhibitors in Geographic Atrophy
Nagre-recruitPhase 2
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07174687A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
Nagre-recruitObservasyonal na pag-aaral
Edad 6 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Nagre-recruitPhase 1/2
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT05197270A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Nagre-recruitPhase 2
Edad 55 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06659549Phase 1 Study of C.001 in Retinal Degeneration
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07594236AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 50 hanggang 89 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06619405A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Nagre-recruitPhase 2/3
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07496567Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Nagre-recruitPhase 1
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07230834Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.